Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Centuri Holdings
CTRI
$2.4B
| $5.55M | ﹤0.01% |
219,670
+37,790
| +21% | +$845K |
|
2127
Kontoor Brands
KTB
$4.51B
| $5.53M | ﹤0.01% |
90,599
+7,956
| +10% | +$591K |
|
2128
Kadant
KAI
$3.94B
| $5.53M | ﹤0.01% |
19,415
+661
| +4% | +$188K |
|
2129
Blackbaud
BLKB
$2.1B
| $5.53M | ﹤0.01% |
87,284
-5,164
| -6% | -$319K |
|
2130
Churchill Downs
CHDN
$6.17B
| $5.53M | ﹤0.01% |
48,570
-25,012
| -34% | -$2.59M |
|
2131
Invesco Solar ETF
TAN
$1.38B
| $5.51M | ﹤0.01% |
112,269
+108,924
| +3,256% | +$5.25M |
|
2132
PUT
Scholar Rock
SRRK
$6.55B
| $5.51M | ﹤0.01% |
125,000
+116,600
| +1,388% | +$4.37M |
|
2133
Xencor
XNCR
$1.72B
| $5.5M | ﹤0.01% |
359,235
-241,110
| -40% | -$3.6M |
|
2134
V2X
VVX
$2.55B
| $5.48M | ﹤0.01% |
100,485
-27,254
| -21% | -$1.53M |
|
2135
Blackstone Mortgage Trust
BXMT
$2.41B
| $5.47M | ﹤0.01% |
285,845
+52,735
| +23% | +$1,000K |
|
2136
Bank of Hawaii
BOH
$3.13B
| $5.46M | ﹤0.01% |
79,885
+19,878
| +33% | +$1.31M |
|
2137
Sable Offshore Corp
SOC
$773M
| $5.45M | ﹤0.01% |
604,654
+408,788
| +209% | +$3.86M |
|
|
PPLI
2138
People Inc
PPLI
$3.02B
| $5.45M | ﹤0.01% |
139,474
-10,588
| -7% | -$371K |
|
2139
CALL
Stellantis
STLA
$20.2B
| $5.45M | ﹤0.01% |
500,000
| – | – |
|
2140
Global X Copper Miners ETF NEW
COPX
$7.97B
| $5.44M | ﹤0.01% |
75,829
+28,373
| +60% | +$1.82M |
|
2141
Supernus Pharmaceuticals
SUPN
$2.78B
| $5.44M | ﹤0.01% |
109,457
-121,732
| -53% | -$5.92M |
|
2142
Invesco Taxable Municipal Bond ETF
BAB
$1.01B
| $5.44M | ﹤0.01% |
200,000
| – | – |
|
2143
CarGurus
CARG
$3.29B
| $5.42M | ﹤0.01% |
141,331
+14,539
| +11% | +$524K |
|
2144
SM Energy
SM
$7.71B
| $5.41M | ﹤0.01% |
289,198
+4,582
| +2% | +$92.8K |
|
2145
CALL
Okta
OKTA
$25.6B
| $5.4M | ﹤0.01% |
62,500
-36,000
| -37% | -$3.14M |
|
|
TGNA
2146
DELISTED
TEGNA Inc
TGNA
| $5.39M | ﹤0.01% |
277,638
+34,080
| +14% | +$673K |
|
2147
Powell Industries
POWL
$7.58B
| $5.39M | ﹤0.01% |
50,682
+4,479
| +10% | +$503K |
|
2148
ICU Medical
ICUI
$4.58B
| $5.38M | ﹤0.01% |
37,705
+3,640
| +11% | +$488K |
|
2149
Community Bank
CBU
$3.43B
| $5.38M | ﹤0.01% |
93,642
+15,942
| +21% | +$917K |
|
2150
Simmons First National
SFNC
$3.45B
| $5.38M | ﹤0.01% |
285,280
+69,035
| +32% | +$1.28M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.